Biodegradable nanogel based on all-trans retinoic acid/pullulan conjugate for anti-cancer drug delivery

Journal of Pharmaceutical Investigation

Volumn 43, Issue 1, 2013, Pages 63-69

  Lee, Jieun ^a   Jeong, Dooyong ^a   Seo, Seogjin ^a   Na, Kun ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

All trans retinoic acid (ATRA); Controlled release; Doxorubicin (DOX); Nanogel; Pullulan

Indexed keywords

DOXORUBICIN; FLUORESCEIN ISOTHIOCYANATE; NANOCARRIER; NANOGEL; PULLULAN; RETINOIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CANCER THERAPY; CELL VIABILITY; CONTROLLED DRUG RELEASE; CYTOTOXICITY; DEGRADATION; DIFFUSION; DRUG SYNTHESIS; DRUG UPTAKE; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HYDRODYNAMICS; HYDROGEL; LIGHT SCATTERING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 84874814649     PISSN: 20935552     EISSN: 20936214     Source Type: Journal    
DOI: 10.1007/s40005-013-0055-6     Document Type: Article

References (29)

1. Allen TM, Mehra T, Hansen C, Chin YC (1992) Stealth liposomes: an improved sustained release system for 1-β-d-arabinofuranosylcytosine. Cancer Res 52(9): 2431-2439.
2. Bae B, Na K (2010) Self-quenching polysaccharide-based nanogels of pullulan/folate-photosensitizer conjugates for photodynamic therapy. Biomaterials 31(24): 6325-6335.
3. Bazile D, Prud'homme C, Bassoullet MT, Marlard M, Spenlehauer G, Veillard M (1995) Stealth Me. PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J Pharm Sci 84(4): 493-498.
4. Dion LD, Gifford GE (1980) Retinoic acid induces a G1 cell cycle block in HeLa cells. Proc Soc Exp Biol Med 163(4): 510-514.
5. Duncan R (2003) The dawning era of polymer. Nat Rev Drug Discov 2: 347.
6. Fischer D, Bieber T, Li Y, Elsässer HP, Kissel T (1999) A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res 16(8): 1273-1279.
7. Ganta S, Devalapally H, Shahiwala A, Amiji M (2008) A review of stimuli-responsive nanocarriers for drug and gene delivery. J Control Release 126(3): 187-204.
8. Gupta P, Vermani K, Garg S (2002) Hydrogels: from controlled release to pH-responsive drug delivery. Drug Discov Today 7(10): 569-579.
9. Iyer AK, Khaled G, Fang J, Maeda H (2006) Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today 11(17): 812-818.
10. Jeong D, Na K (2012) Chondroitin sulfate based nanocomplex for enhancing the stability and activity of anthocyanin. Carbohydr Polym 90(1): 507-515.
11. Jeong B, Bae YH, Lee DS, Kim SW (1997) Biodegradable block copolymers as injectable drug-delivery systems. Nature 388(6645): 860-862.
12. Jeong D, Seo S, Na K (2012) Drug stabilization and controlled release from AB 3 type tetra block copolymer based polymersome. J Pharm Investig 42: 1-8.
13. Kazunori K, Glenn SK, Masayuki Y, Teruo O, Yasuhisa S (1993) Block copolymer micelles as vehicles for drug delivery. J Control Release 24(1): 119-132.
14. Langer R (1980) Invited review polymeric delivery systems for controlled drug release. Chem Eng Commun 6(1-3): 1-48.
15. Lee ES, Park KH, Kang D, Park IS, Min HY, Lee DH, Kim S, Kim JH, Na K (2007) Protein complexed with chondroitin sulfate in poly (lactide-co-glycolide) microspheres. Biomaterials 28(17): 2754-2762.
16. Leroueil PR, Berry SA, Duthie K, Han G, Rotello VM, McNerny DQ, Baker JR Jr, Orr BG, Holl MMB (2008) Wide varieties of cationic nanoparticles induce defects in supported lipid bilayers. Nano Lett 8(2): 420-424.
17. Li SD, Huang L (2009) Nanoparticles evading the reticuloendothelial system: role of the supported bilayer. Biochim Biophys Acta 1788(10): 2259-2266.
18. Liu M, Fréchet JMJ (1999) Designing dendrimers for drug delivery. Pharm Sci Technol Today 2(10): 393-401.
19. Lotan R (1995) Retinoids and apoptosis: implications for cancer chemoprevention and therapy. J Natl Cancer Inst 87(22): 1655-1657.
20. Lynch I, Dawson KA (2008) Protein-nanoparticle interactions. Nano Today 3(1): 40-47.
21. Moghimi S, Szebeni J (2003) Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res 42(6): 463-478.
22. Müller R, Radtke M, Wissing S (2002) Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 242(1): 121-128.
23. Na K, Park KH, Kim SW, Bae YH (2000) Self-assembled hydrogel nanoparticles from curdlan derivatives: characterization, anti-cancer drug release and interaction with a hepatoma cell line (HepG2). J Control Release 69(2): 225-236.
24. Ogris M, Kotha AK, Tietze N, Wagner E, Palumbo FS, Giammona G, Cavallaro G (2007) Novel biocompatible cationic copolymers based on polyaspartylhydrazide being potent as gene vector on tumor cells. Pharm Res 24(12): 2213-2222.
25. Petkovich M, Brand NJ, Krust A, Chambon P (1987) A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330(6147): 444-450.
26. Seo SJ, Moon HS, Guo DD, Kim SH, Akaike T, Cho CS (2006) Receptor-mediated delivery of all-trans-retinoic acid (ATRA) to hepatocytes from ATRA-loaded poly N-p-vinylbenzyl-4-o-β-d-galactopyranosyl-d-gluconamide) nanoparticles. Mater Sci Eng C 26(1): 136-141.
27. Teramoto N, Shibata M (2006) Synthesis and properties of pullulan acetate. Thermal properties, biodegradability, and a semi-clear gel formation in organic solvents. Carbohydr Polym 63(4): 476-481.
28. Torchilin VP (2001) Structure and design of polymeric surfactant-based drug delivery systems. J Control Release 73(2-3): 137.
29. Wong HL, Bendayan R, Rauth AM, Xue HY, Babakhanian K, Wu XY (2006) A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system. J Pharmacol Exp Ther 317(3): 1372-1381.